Baseline characteristics

Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer · Source last updated 2017-04-17

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      82

   2. group Id

      BG001

      value

      86

   3. group Id

      BG002

      value

      168

   units

   Participants

groups

1. description

   Period 1: Participants received 4 overencapsulated capsules of sunitinib, each containing 12.5 milligrams (mg) of sunitinib, once daily (OD) orally for 4 weeks, followed by 2 weeks off treatment (matching placebo capsules to maintain blind), followed by 50 mg (4 x 12.5 mg) OD orally for 4 weeks. Period 1 was followed by a 2-week wash-out period in which no treatment was given. Period 2: Participants received 4 overencapsulated tablets of pazopanib, each containing 200 mg of pazopanib, OD orally for 10 weeks. Study drugs were taken without food at least one hour before or two hours after a meal. The capsules were swallowed whole and not crushed or broken. The time of day the study drugs were taken remained relatively constant.

   id

   BG000

   title

   Sunitinib 50 mg Followed by Pazopanib 800 mg

2. description

   Period 1: Participants received 4 overencapsulated tablets of pazopanib, each containing 200 mg of pazopanib, OD orally for 10 weeks. Period 1 was followed by a 2-week wash-out period in which no treatment was given. Period2: Participants received 4 overencapsulated capsules of sunitinib, each containing 12.5 mg of sunitinib, OD orally for 4 weeks, followed by 2 weeks off treatment (matching placebo capsules to maintain blind), followed by 50 mg (4 x 12.5 mg) OD orally for 4 weeks. Study drugs were taken without food at least one hour before or two hours after a meal. The capsules were swallowed whole and not crushed or broken. The time of day the study drugs were taken remained relatively constant.

   id

   BG001

   title

   Pazopanib 800 mg Followed by Sunitinib 50 mg

3. description

   Total of all reporting groups

   id

   BG002

   title

   Total

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            9.56

            value

            62.1

         2. group Id

            BG001

            spread

            11.35

            value

            62.2

         3. group Id

            BG002

            spread

            10.48

            value

            62.2

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age, Continuous

   unit Of Measure

   Years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            30

         2. group Id

            BG001

            value

            25

         3. group Id

            BG002

            value

            55

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            52

         2. group Id

            BG001

            value

            61

         3. group Id

            BG002

            value

            113

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            1

         2. group Id

            BG001

            value

            0

         3. group Id

            BG002

            value

            1

      title

      African American/African Heritage

   2. categories

      1. measurements

         1. group Id

            BG000

            value

            1

         2. group Id

            BG001

            value

            0

         3. group Id

            BG002

            value

            1

      title

      Asian-Central/South Asian Heritage

   3. categories

      1. measurements

         1. group Id

            BG000

            value

            74

         2. group Id

            BG001

            value

            83

         3. group Id

            BG002

            value

            157

      title

      White

   4. categories

      1. measurements

         1. group Id

            BG000

            value

            6

         2. group Id

            BG001

            value

            3

         3. group Id

            BG002

            value

            9

      title

      Missing

   param Type

   NUMBER

   title

   Race/Ethnicity, Customized

   unit Of Measure

   participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice